- Home
- KIDZW vs FBIOP Comparison
KIDZW vs FBIOP Comparison
Compare KIDZW & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KIDZW | FBIOP |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | 2025 | 2011 |
Fundamental Metrics
Financial Performance| Metric | KIDZW | FBIOP |
|---|---|---|
| Price | $0.01 | $18.26 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 88.8K | 11.6K |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 97.40 |
| EPS | N/A | ★ 2.86 |
| Revenue | $3,366,421.00 | ★ $63,262,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $6.37 |
| Revenue Growth | N/A | ★ 9.69 |
| 52 Week Low | $0.01 | $6.27 |
| 52 Week High | $0.15 | $21.43 |
Technical Indicators
Market Signals| Indicator | KIDZW | FBIOP |
|---|---|---|
| Relative Strength Index (RSI) | 39.24 | 36.67 |
| Support Level | N/A | $17.90 |
| Resistance Level | $0.02 | $19.00 |
| Average True Range (ATR) | 0.00 | 0.56 |
| MACD | -0.00 | -0.12 |
| Stochastic Oscillator | 21.05 | 10.25 |
Price Performance
Historical ComparisonAbout KIDZW Classover Holdings Inc. Warrants
KIDZ AI Inc is an AI-driven education technology company transforming live teaching experience into proprietary AI-powered learning systems. By integrating artificial intelligence, AI agents, and robotics, it is building a world-wide education infrastructure designed to make learning outcomes measurable, verifiable, and accessible across borders. The Company is strategically expanding into AI compute infrastructure, GPU cloud platforms, and data center ecosystems.
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.